Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Howard (London, United Kingdom), K. Chin (Dallas, United States of America), Y. Fong (Allschwil, Switzerland), C. Gargano (Allschwil, Switzerland), D. Stamatiadis (Allschwil, Switzerland), B. Maron (Boston, United States of America), I. Preston (Boston, United States of America), D. Quinn (Allschwil, Switzerland), S. Rosenkranz (Cologne, Germany), M. Toshner (Cambridge, United Kingdom), M. Wilkins (London, United Kingdom), D. Kiely (Sheffield, United Kingdom). CIPHER: a prospective, multicentre study for the identification of biomarker signatures for early detection of pulmonary hypertension. 1531

Member's Comments

No comment yet.

Related content which might interest you: Development of a new prognosis index (BODS) in patients with COPD:a prospective cohort study Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)? Year: 2018 Discovery of novel disease-related biomarkers for GOLD stage II COPD: A prospective exploratory clinical study Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010 An international prospective cohort study to develop a practical COPD disease risk index that predicts the clinical course of COPD Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care Year: 2009 A prospective study comparing the repeatability and sensitivity to change of non-invasive endpoints in pulmonary arterial hypertension: the RESPIRE study Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension Year: 2019 Late Breaking Abstract - A composite serum biomarker index for the diagnosis of systemic sclerosis associated interstitial lung disease: a multicentre, observational, cohort study Source: Virtual Congress 2021 – New approaches to diagnostic and prognostic evaluation of interstitial lung diseases of known causes Year: 2021 Phenotypic characterisation of early COPD: a prospective case–control study Source: ERJ Open Res, 6 (4) 00047-2020; 10.1183/23120541.00047-2020 Year: 2020 The added value of comorbidities in predicting survival in idiopathic pulmonary fibrosis: a multicentre observational study Source: Eur Respir J, 53 (3) 1801587; 10.1183/13993003.01587-2018 Year: 2019 Aspergillus pulmonary disease in cystic fibrosis (CF) patients: multicentre perspective observational study based on new diagnostic tests to evaluate the prognostic value on the CF disease Source: Virtual Congress 2021 – Adult cystic fibrosis Year: 2021 Early detection of COPD: evidence from a population cohort study Source: Annual Congress 2007 - Environmental and clinical aspects of COPD Year: 2007 Easy-use device for screening COPD in primary care: prospective validation study Source: Annual Congress 2007 - Managing COPD in primary care Year: 2007 A new prospective multicenter study of EBV treatment of homogeneous disease: A status report Source: Annual Congress 2013 –Endoscopic lung volume reduction & newest clinical data Year: 2013 1-year prospective study in severe COPD patients: marker of inflammation, lung function and radiologic evaluation Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 Prognostic factors of pulmonary embolism: results of a prospective multicenter study Source: Annual Congress 2008 - Acute and chronic pulmonary thromboembolic disease Year: 2008 Do marker states improve measurement properties of utility instruments: a randomized multi-center trial in patients with chronic respiratory disease Source: Eur Respir J 2004; 24: Suppl. 48, 295s Year: 2004 Quantitative analysis of lung sounds for monitoring idiopathic pulmonary fibrosis: a prospective pilot study Source: Eur Respir J, 53 (3) 1802093; 10.1183/13993003.02093-2018 Year: 2019 Early symptoms in suspected lung cancer: a prospective cohort study Source: Eur Respir J 2001; 18: Suppl. 33, 64s Year: 2001 D-dimer as a predictor of persistent pulmonary function impairment after COVID-19 pneumonia: a prospective observational study Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases Year: 2021 Early treatment of borderline pulmonary arterial hypertension associated with systemic sclerosis: a randomized, controlled, double-blind, parallel group, proof-of-concept study Source: International Congress 2018 – Risk stratification in treatment of pulmonary arterial hypertension Year: 2018 Characteristics and clinical management of IPF patients in Spain: prospective, observational, multicentric study (OASIS study). Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020 A multicentre, observational cohort study to determine the efficacy and safety of lumacaftor/ivacaftor in patients with severe lung disease and cystic fibrosis Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis Year: 2019